Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Ins... von Mellbin, L. G., Malmberg, K., Norhammar, A., Wedel, H., Rydén, L.

Volltext

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial von Mellbin, L G, Malmberg, K, Waldenström, A, Wedel, H, Rydén, L

Volltext

Clinical implications of cardiovascular outcome trials in type 2 diabetes von Mellbin, L. G., Wang, A., Rydén, L.

Volltext

Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial von MELLBIN, L. G, HAMSTEN, A, MALMBERG, K, STEFFENSEN, R, RYDEN, L, ÖHRVIK, J, HANSEN, T. K

Volltext

Patients With Type 2 Diabetes Have an Increased Demand for Pacemaker Treatment: A Comparison With Age- and Sex-Matched Control Subjects From the General Population von Rautio, Elina, Gadler, Fredrik, Gudbjornsdottir, Soffia, Franzen, Stefan, Ryden, Lars, Svensson, Ann-Marie, Mellbin, Linda G.

Volltext

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial von Mellbin, Linda G., Malmberg, Klas, Norhammar, Anna, Wedel, Hans, Rydén, Lars

Volltext

Copeptin is associated with mortality in elderly people von Smaradottir, Maria Isabel, Andersen, Karl, Gudnason, Vilmundur, Näsman, Per, Rydén, Lars, Mellbin, Linda Garcia

Volltext

Clinical implications of cardiovascular outcome trials in type2diabetes von Mellbin, LG, Wang, A, Ryden, L

Volltext

The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial von Mellbin, Linda G, Malmberg, Klas, Rydén, Lars, Wedel, Hans, Vestberg, Daniel, Lind, Marcus

Volltext

Copeptin and coronary artery calcium score in elderly adults without a cardiovascular history. A report from the ICELAND MI cohort von Smaradottir, M. I., Andersen, K., Eiriksdottir, G., Gudnason, V., Näsman, Per, Ryden, L., Mellbin, L. G.

Volltext

Vasopressin, measured as copeptin, in elderly individuals with or without unrecognized myocardial infarction. A report from the ICELAND MI Cohort von Smaradottir, M I, Andersen, K, Gudnason, V, Näsman, Per, Ryden, L, Mellbin, L G

Volltext

Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities – A marker of increased stress susceptibility? A report from the Glucose in Acute Myo... von Smaradottir, Maria Isabel, Ritsinger, Viveca, Gyberg, Viveca, Norhammar, Anna, Näsman, Per, Mellbin, Linda G

Volltext

Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction von Mellbin, L.G., Hamsten, A., Malmberg, K., Steffensen, R., Rydén, L., Öhrvik, J., Hansen, T.K.

Volltext

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds/Leeds Teaching Hospitals NHS Trust, LIGHT Laboratories, Clarendon Way von Cosentino, F., Grant, P. J., Aboyans, V., Bailey, G. J., Ceriello, А., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. В., Huikuri, H. V., Johansson, I., Jüni, P., Lettino, M., Marx, N., Mellbin, L. G., Östgren, C. J., Rocca, B., Roffi, M., Sattar, N., Seferović, P. M., Sousa-Uva, M., Valensi, P., Wheeler, D. C.

Volltext

Testosterone in patients with acute myocardial infarction and glucose abnormalities and in matched controls: a report from the GAMI study von Wang, A., Arver, S., Flanagan, J., Mellbin, L. G., Gyberg, V., Malmberg, K., Norhammar, A., Näsman, Per, Ritsinger, V., Ryden, L.

Volltext

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial von Mellbin, Linda G, Rydén, Lars, Riddle, Matthew C, Probstfield, Jeffrey, Rosenstock, Julio, Díaz, Rafael, Yusuf, Salim, Gerstein, Hertzel C

Volltext

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD von Cosentino, Francesco, Grant, Peter J, Aboyans, Victor, Bailey, Clifford J, Ceriello, Antonio, Delgado, Victoria, Federici, Massimo, Filippatos, Gerasimos, Grobbee, Diederick E, Hansen, Tina Birgitte, Huikuri, Heikki V, Johansson, Isabelle, Jüni, Peter, Lettino, Maddalena, Marx, Nikolaus, Mellbin, Linda G, Östgren, Carl J, Rocca, Bianca, Roffi, Marco, Sattar, Naveed, Seferović, Petar M, Sousa-Uva, Miguel, Valensi, Paul, Wheeler, David C

Volltext

P4496Copeptin and coronary artery calcium score in elderly adults without a cardiovascular history. A report from the ICELAND MI cohort von Smaradottir, M I, Andersen, K, Eiriksdottir, G, Gudnason, V, Nasman, P, Ryden, L, Mellbin, L G

Volltext

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials von Mellbin, Linda G, Bhatt, Deepak L, David, Jens-Peter, Ekström, Kathrine, Petrie, Mark C, Rasmussen, Søren, Vilsbøll, Tina

Volltext

Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis von Ferrannini, Giulia, Mellbin, Linda G., Kirabo, Faith, Ramasundarahettige, Chinthanie, Gerstein, Hertzel C., Rydén, Lars

Volltext